Literature DB >> 20725579

The botulinum toxin experience: results of a patient self-report questionnaire.

Richard G Fried, Wm Philip Werschler, Tracy Floirendo.   

Abstract

There are several words in our current vernacular that reliably elicit powerful cognitive, visual, and emotional reactions in the populace. Undoubtedly, "Botox()" is one of them. Beyond issues regarding the safety of the molecule, there are controversies surrounding the overall legitimacy of the cosmetic use of botulinum toxin type A-1. Many people question whether the cosmetic use of botulinum toxin type A-1 is a "legitimate" medical procedure versus a cosmetic indulgence. The authors report data obtained from a patient self-report questionnaire designed to assess positive or negative changes in feelings and functional status after botulinum toxin type A-1 treatment of the forehead and glabellar region. The authors developed concrete, succinct, and pointed questions pertaining to spheres of function (i.e., work, social, family, intrapsychic, and intimate functioning). Results of this pilot study serve as a persuasive preliminary database to argue that botulinum toxin therapy is more than simply an indulgence therapy.

Entities:  

Year:  2009        PMID: 20725579      PMCID: PMC2923936     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  8 in total

Review 1.  Critical review of generic and dermatology-specific health-related quality of life instruments.

Authors:  Hilde Both; Marie-Louise Essink-Bot; Jan Busschbach; Tamar Nijsten
Journal:  J Invest Dermatol       Date:  2007-11-08       Impact factor: 8.551

Review 2.  Botulinum toxin and the facial feedback hypothesis: can looking better make you feel happier?

Authors:  Murad Alam; Karen C Barrett; Robert M Hodapp; Kenneth A Arndt
Journal:  J Am Acad Dermatol       Date:  2008-06       Impact factor: 11.527

3.  Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

Authors:  A Y Finlay; G K Khan
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

4.  Treatment of depression with botulinum toxin A: a case series.

Authors:  Eric Finzi; Erika Wasserman
Journal:  Dermatol Surg       Date:  2006-05       Impact factor: 3.398

5.  Cutaneous and psychosocial benefits of alpha hydroxy acid use.

Authors:  R G Fried; T F Cash
Journal:  Percept Mot Skills       Date:  1998-02

6.  Satisfaction of patients after treatment with botulinum toxin for dynamic facial lines.

Authors:  Boris Sommer; Ina Zschocke; Dorothee Bergfeld; Gerhard Sattler; Matthias Augustin
Journal:  Dermatol Surg       Date:  2003-05       Impact factor: 3.398

Review 7.  Social implications of hyperfunctional facial lines.

Authors:  J Charles Finn; Sue Ellen Cox; Melissa L Earl
Journal:  Dermatol Surg       Date:  2003-05       Impact factor: 3.398

8.  Facial aesthetics: achieving the natural, relaxed look.

Authors:  Alastair Carruthers; Joel L Cohen; Sue Ellen Cox; Koenraad De Boulle; Steven Fagien; Charles J Finn; Timothy Flynn; Nicholas J Lowe; Hervé Raspaldo; Boris Sommer; Ada Trindade de Almeida
Journal:  J Cosmet Laser Ther       Date:  2007       Impact factor: 2.247

  8 in total
  3 in total

1.  Filler cheeks: a bright idea? The "eyes" have it.

Authors:  Richard G Fried
Journal:  J Clin Aesthet Dermatol       Date:  2011-05

2.  Patient-perceived Emotional and Functional Benefits of Poly-L-Lactic Acid (PLLA) for the Treatment of Facial Volume Loss.

Authors:  Richard Fried; W Phillip Werschler; Judith Cenci; Lauren Sternberg; Priya Dhanaraj; Dara Tolas; Suzanne Withrow
Journal:  J Clin Aesthet Dermatol       Date:  2018-07-01

3.  Perceived Stress and Interest in Non-Invasive Aesthetic Procedures During the COVID-19 Pandemic.

Authors:  Sylvia P B Ramirez; Gunther Scherz; Helen Smith
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-07-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.